ANDA 87744, held by Pharmobedient. Chlorothiazide; Reserpine.
As of Nov 16, 2026, ANDA 87744 (Chlorothiazide-Reserpine), held by Pharmobedient, was first approved by FDA on May 6, 1982, with 9 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 6, 1982 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Chlorothiazide-Reserpine250MG;0.125MG ยท tablet;oral | Chlorothiazide; Reserpine | Discontinued |
| Feb 25, 1998 | Supplement 12Manufacturing | Approved | None posted |
| Feb 5, 1998 | Supplement 13Manufacturing | Approved | None posted |
| Mar 7, 1994 | Supplement 11Manufacturing | Approved | None posted |
| Feb 12, 1993 | Supplement 9Labeling | Approved | None posted |
| Jan 31, 1990 | Supplement 8Manufacturing | Approved | None posted |
| Jun 22, 1989 | Supplement 7Labeling | Approved | None posted |
| May 4, 1988 | Supplement 6Labeling | Approved | None posted |
| Mar 25, 1986 | Supplement 4Manufacturing | Approved | None posted |
| Sep 18, 1984 | Supplement 2Manufacturing | Approved | None posted |
| May 6, 1982 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters